Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7319 p455
2 October 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Hospital admission risk for non-adherent diabetes patients

Patients with type 2 diabetes who do not take their antihyperglycaemic medicines properly increase their risk of admission to hospital.

A US study analysed 900 participants with type 2 diabetes in a managed care scheme between 2000 and 2001. Around a third of patients were found to have poor adherence with oral antihyperglycaemics, defined as obtaining less than 80 per cent of prescribed medicines. Almost 46 per cent were on multiple antiglycaemic drug therapies, 45 per cent received at least one prescription for a lipid modifying agent and antihypertensives were prescribed for 57 per cent.

Patients who failed to adhere to their oral diabetes medication in 2000 were 2.5 times as likely to be admitted to hospital for diabetes or cardiovascular or cerebrovascular conditions in the following year as adherent patients.

Non-adherence to drugs for hypertension and dyslipidaemia were not significantly associated with hospital admission.

The authors say that strategies to identify and intervene with the poorly adherent could bring substantial benefits to both patients and providers of health care services (Diabetes Care 2004;27:2149-53).

Back to Top


©The Pharmaceutical Journal